Skip to main content

Table 2 Subgroup analyses for overall survival

From: Perioperative transfusion and the prognosis of colorectal cancer surgery: a systematic review and meta-analysis

Stratified

No. of studies

I2 (%)

HR (95% CI)

P value

Publication date (year)

 1990–2000

4

0

0.17 (0, 0.34)

0.049

 2001–2010

7

4.5

0.32 (0.19, 0.45)

< 0.0001

 2011–2018

14

74.7

0.37 (0.25, 0.48)

< 0.0001

Study size (no. of patients)

 < 500

9

63.1

0.42 (0.12, 0.71)

0.005

 ≥ 500

5

63.1

0.32 (0.23, 0.40)

< 0.0001

Region

 Asia

4

0

0.31 (0.17, 0.45)

< 0.0001

 Europe

12

56.9

0.29 (0.12, 0.46)

0.0001

 America

5

88.7

0.40 (0.22, 0.57)

< 0.0001

 Australia

3

0

0.29 (0.14, 0.44)

< 0.0001

Surgical type

 Colorectal

18

48.6

0.31 (0.21, 0.41)

< 0.0001

 Colonic

4

59.8

0.37 (0.23, 0.52)

< 0.0001

 Rectal

2

63.8

0.28(− 0.21, − 0.77)

0.258

  1. No. number, HR hazard ratio, 95% CI 95% confidence interval